Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Oncternal Therapeutics, Inc. ONCT
$0.29
-$0.01 (-3.15%)
На 18:01, 12 мая 2023
+5 072.41%
Потенциал через год
Ранг: 3
Ключевые показатели
-
Marketcap
17055691.00000000
-
week52high
1.87
-
week52low
0.26
-
Revenue
0
-
P/E TTM
0
-
Beta
1.30875100
-
EPS
-0.82000000
-
Last Dividend
0.00000000
-
Next Earnings Date
04 мая 2023 г. в 20:00
Описание компании
Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of oncology therapies for cancers with critical unmet medical needs. The company's clinical pipeline includes zilovertamab, a humanized monoclonal antibody that binds to receptor-tyrosine kinase-like Orphan Receptor 1 (ROR1); and ONCT-216, a small molecule inhibiting the biological activity of ETS-family transcription factor oncoproteins. It is also developing ONCT-808, a chimeric antigen receptor T-cells (CAR-T) product candidate that targets ROR1; and ONCT-534, a dual-action androgen receptor inhibitor product candidate for the treatment of castration-resistant prostate and other androgen receptor-driven cancers. Oncternal Therapeutics, Inc. has license agreements with the Regents of the University of California; Georgetown University; The University of Texas MD Anderson Cancer Center; Shanghai Pharmaceutical (USA) Inc.; and University of Tennessee Research Foundation. Oncternal Therapeutics, Inc. has a research collaboration with Celularity Inc. to evaluate placental derived-cellular therapies targeting ROR1. The company is headquartered in San Diego, California.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| HC Wainwright & Co. | Buy | Buy | 10 авг 2022 г. |
| Maxim Group | Buy | 10 мая 2022 г. | |
| BTIG | Buy | 24 февр 2022 г. | |
| Oppenheimer | Outperform | 07 апр 2021 г. | |
| Brookline Capital | Buy | 30 мар 2021 г. | |
| Cantor Fitzgerald | Overweight | 22 дек 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| DeSimone Jill | A | 50000 | 50000 | 04 янв 2023 г. |
| VINCENT RICHARD G | D | 126859 | 4428 | 03 янв 2023 г. |
| Yazji Salim | D | 139676 | 9961 | 03 янв 2023 г. |
| Kaufmann Gunnar F. | D | 66726 | 6266 | 03 янв 2023 г. |
| Leavitt Chase C. | D | 81901 | 6091 | 03 янв 2023 г. |
| BREITMEYER JAMES B | D | 23918 | 1325 | 03 янв 2023 г. |
| BREITMEYER JAMES B | D | 541981 | 27793 | 03 янв 2023 г. |
| Krishnan Rajesh | D | 66754 | 6238 | 03 янв 2023 г. |
| Leavitt Chase C. | A | 28750 | 28750 | 28 июл 2022 г. |
| Leavitt Chase C. | A | 87992 | 43125 | 28 июл 2022 г. |
Новостная лента
Oncternal Therapeutics, Inc. (ONCT) Q1 2023 Earnings Call Transcript
Seeking Alpha
04 мая 2023 г. в 22:53
Oncternal Therapeutics, Inc. (NASDAQ:ONCT ) Q1 2023 Results Conference Call May 4, 2023 5:00 PM ET Company Participants Salim Yazji - CMO James Breitmeyer - President, CEO Richard Vincent - CFO Conference Call Participants Hartaj Singh - Oppenheimer Carl Byrnes - Northland Capital Markets Rosemary Li - Cantor Fitzgerald Kemp Dolliver - Brookline Capital Markets Operator Greetings, and welcome to the Oncternal Therapeutics First Quarter 2023 Financial Results Call. [Operator Instructions] As a reminder, this conference will be recorded.
Oncternal Therapeutics (ONCT) Reports Q1 Loss, Tops Revenue Estimates
Zacks Investment Research
04 мая 2023 г. в 19:44
Oncternal Therapeutics (ONCT) came out with a quarterly loss of $0.20 per share versus the Zacks Consensus Estimate of a loss of $0.21. This compares to loss of $0.20 per share a year ago.
Penny Stocks To Buy? 10 Under $1 To Watch This Week
PennyStocks
19 апр 2023 г. в 15:29
Penny stocks under $1 to watch this week. The post Penny Stocks To Buy?
Penny Stocks To Buy? 7 Under $1 To Watch This Week
PennyStocks
17 апр 2023 г. в 11:15
Penny stocks to watch trading for pennies this week. The post Penny Stocks To Buy?
Oncternal (ONCT) Down on Restructuring Plan to Extend Runway
Zacks Investment Research
04 апр 2023 г. в 13:42
Oncternal (ONCT) closes the development program for zilovertamab to extend its cash runway into 2025. Shares are down on the same.